miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts

Anna M. Eiring; Jason G. Harb; Paolo Neviani; Christopher Garton; Joshua J. Oaks; Riccardo Spizzo; Shujun Liu; Sebastian Schwind; Ramasamy Santhanam; Christopher J. Hickey; Heiko Becker; Jason C. Chandler; Raul Andino; Jorge Cortes; Peter Hokland; Claudia S. Huettner; Ravi Bhatia; Denis C. Roy; Stephen A. Liebhaber; Michael A. Caligiuri; Guido Marcucci; Ramiro Garzon; Carlo M. Croce; George A. Calin; Danilo Perrotti

doi:10.1016/j.cell.2010.01.007

miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts

Anna M. Eiring, Jason G. Harb, Paolo Neviani, Christopher Garton, Joshua J. Oaks, Riccardo Spizzo, Shujun Liu, Sebastian Schwind, Ramasamy Santhanam, Christopher J. Hickey, Heiko Becker, Jason C. Chandler, Raul Andino, Jorge Cortes, Peter Hokland, Claudia S. Huettner, Ravi Bhatia, Denis C. Roy, Stephen A. Liebhaber, Michael A. CaligiuriGuido Marcucci, Ramiro Garzon, Carlo M. Croce, George A. Calin, Danilo Perrotti

Research output: Contribution to journal › Article › peer-review

464 Scopus citations

Abstract

MicroRNAs and heterogeneous ribonucleoproteins (hnRNPs) are posttranscriptional gene regulators that bind mRNA in a sequence-specific manner. Here, we report that loss of miR-328 occurs in blast crisis chronic myelogenous leukemia (CML-BC) in a BCR/ABL dose- and kinase-dependent manner through the MAPK-hnRNP E2 pathway. Restoration of miR-328 expression rescues differentiation and impairs survival of leukemic blasts by simultaneously interacting with the translational regulator poly(rC)-binding protein hnRNP E2 and with the mRNA encoding the survival factor PIM1, respectively. The interaction with hnRNP E2 is independent of the microRNA's seed sequence and it leads to release of CEBPA mRNA from hnRNP E2-mediated translational inhibition. Altogether, these data reveal the dual ability of a microRNA to control cell fate both through base pairing with mRNA targets and through a decoy activity that interferes with the function of regulatory proteins. PaperFlick: {An electronic component is presented}.

Original language	English (US)
Pages (from-to)	652-665
Number of pages	14
Journal	Cell
Volume	140
Issue number	5
DOIs	https://doi.org/10.1016/j.cell.2010.01.007
State	Published - Mar 5 2010
Externally published	Yes

Bibliographical note

Funding Information:
This work was supported in part by grants from the National Cancer Institute CA095512 (D.P.), CA16058 (OSU-CCC), NIH, Bethesda, MD, USA; the US Army, CML Research Program, W81XWH-07-1-0270 (D.P.); the American-Italian Cancer Foundation (P.N.); Fonds de la Recherche en Sante du Quebec (D.C.R.); and AGGRS from The OSU Graduate School (A.M.E.). D.P. is a Scholar of The Leukemia and Lymphoma Society. G.A.C. is a Fellow of the M.D. Anderson Research Trust and Scholar of the University of Texas System Regents. We thank J.-S. Chang, M. Odeh, and A. Martin for technical assistance and S. Lee for editorial assistance; T. Skorski (Temple University, Philadelphia, PA, USA) for providing PIM1 cDNAs; F. Racke (OSU, Columbus OH, USA) for histopathology analysis; B. Calabretta (TJU, Philadelphia, PA, USA), R. Arlinghaus (MDACC, Houston, TX, USA), and K. Huebner (OSU) for critical reading of the manuscript.

Keywords

HUMDISEASE
RNA

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1016/j.cell.2010.01.007

Find It

Find It at U of M Libraries

Cite this

Eiring, A. M., Harb, J. G., Neviani, P., Garton, C., Oaks, J. J., Spizzo, R., Liu, S., Schwind, S., Santhanam, R., Hickey, C. J., Becker, H., Chandler, J. C., Andino, R., Cortes, J., Hokland, P., Huettner, C. S., Bhatia, R., Roy, D. C., Liebhaber, S. A., ... Perrotti, D. (2010). miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts. Cell, 140(5), 652-665. https://doi.org/10.1016/j.cell.2010.01.007

Eiring, AM, Harb, JG, Neviani, P, Garton, C, Oaks, JJ, Spizzo, R, Liu, S, Schwind, S, Santhanam, R, Hickey, CJ, Becker, H, Chandler, JC, Andino, R, Cortes, J, Hokland, P, Huettner, CS, Bhatia, R, Roy, DC, Liebhaber, SA, Caligiuri, MA, Marcucci, G, Garzon, R, Croce, CM, Calin, GA & Perrotti, D 2010, 'miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts', Cell, vol. 140, no. 5, pp. 652-665. https://doi.org/10.1016/j.cell.2010.01.007

@article{1e17ce1ef3ed45a8b82719124bbfdfa6,

title = "miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts",

abstract = "MicroRNAs and heterogeneous ribonucleoproteins (hnRNPs) are posttranscriptional gene regulators that bind mRNA in a sequence-specific manner. Here, we report that loss of miR-328 occurs in blast crisis chronic myelogenous leukemia (CML-BC) in a BCR/ABL dose- and kinase-dependent manner through the MAPK-hnRNP E2 pathway. Restoration of miR-328 expression rescues differentiation and impairs survival of leukemic blasts by simultaneously interacting with the translational regulator poly(rC)-binding protein hnRNP E2 and with the mRNA encoding the survival factor PIM1, respectively. The interaction with hnRNP E2 is independent of the microRNA's seed sequence and it leads to release of CEBPA mRNA from hnRNP E2-mediated translational inhibition. Altogether, these data reveal the dual ability of a microRNA to control cell fate both through base pairing with mRNA targets and through a decoy activity that interferes with the function of regulatory proteins. PaperFlick: {An electronic component is presented}.",

keywords = "HUMDISEASE, RNA",

author = "Eiring, {Anna M.} and Harb, {Jason G.} and Paolo Neviani and Christopher Garton and Oaks, {Joshua J.} and Riccardo Spizzo and Shujun Liu and Sebastian Schwind and Ramasamy Santhanam and Hickey, {Christopher J.} and Heiko Becker and Chandler, {Jason C.} and Raul Andino and Jorge Cortes and Peter Hokland and Huettner, {Claudia S.} and Ravi Bhatia and Roy, {Denis C.} and Liebhaber, {Stephen A.} and Caligiuri, {Michael A.} and Guido Marcucci and Ramiro Garzon and Croce, {Carlo M.} and Calin, {George A.} and Danilo Perrotti",

note = "Funding Information: This work was supported in part by grants from the National Cancer Institute CA095512 (D.P.), CA16058 (OSU-CCC), NIH, Bethesda, MD, USA; the US Army, CML Research Program, W81XWH-07-1-0270 (D.P.); the American-Italian Cancer Foundation (P.N.); Fonds de la Recherche en Sante du Quebec (D.C.R.); and AGGRS from The OSU Graduate School (A.M.E.). D.P. is a Scholar of The Leukemia and Lymphoma Society. G.A.C. is a Fellow of the M.D. Anderson Research Trust and Scholar of the University of Texas System Regents. We thank J.-S. Chang, M. Odeh, and A. Martin for technical assistance and S. Lee for editorial assistance; T. Skorski (Temple University, Philadelphia, PA, USA) for providing PIM1 cDNAs; F. Racke (OSU, Columbus OH, USA) for histopathology analysis; B. Calabretta (TJU, Philadelphia, PA, USA), R. Arlinghaus (MDACC, Houston, TX, USA), and K. Huebner (OSU) for critical reading of the manuscript. ",

year = "2010",

month = mar,

day = "5",

doi = "10.1016/j.cell.2010.01.007",

language = "English (US)",

volume = "140",

pages = "652--665",

journal = "Cell",

issn = "0092-8674",

publisher = "Cell Press",

number = "5",

}

TY - JOUR

T1 - miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts

AU - Eiring, Anna M.

AU - Harb, Jason G.

AU - Neviani, Paolo

AU - Garton, Christopher

AU - Oaks, Joshua J.

AU - Spizzo, Riccardo

AU - Liu, Shujun

AU - Schwind, Sebastian

AU - Santhanam, Ramasamy

AU - Hickey, Christopher J.

AU - Becker, Heiko

AU - Chandler, Jason C.

AU - Andino, Raul

AU - Cortes, Jorge

AU - Hokland, Peter

AU - Huettner, Claudia S.

AU - Bhatia, Ravi

AU - Roy, Denis C.

AU - Liebhaber, Stephen A.

AU - Caligiuri, Michael A.

AU - Marcucci, Guido

AU - Garzon, Ramiro

AU - Croce, Carlo M.

AU - Calin, George A.

AU - Perrotti, Danilo

N1 - Funding Information: This work was supported in part by grants from the National Cancer Institute CA095512 (D.P.), CA16058 (OSU-CCC), NIH, Bethesda, MD, USA; the US Army, CML Research Program, W81XWH-07-1-0270 (D.P.); the American-Italian Cancer Foundation (P.N.); Fonds de la Recherche en Sante du Quebec (D.C.R.); and AGGRS from The OSU Graduate School (A.M.E.). D.P. is a Scholar of The Leukemia and Lymphoma Society. G.A.C. is a Fellow of the M.D. Anderson Research Trust and Scholar of the University of Texas System Regents. We thank J.-S. Chang, M. Odeh, and A. Martin for technical assistance and S. Lee for editorial assistance; T. Skorski (Temple University, Philadelphia, PA, USA) for providing PIM1 cDNAs; F. Racke (OSU, Columbus OH, USA) for histopathology analysis; B. Calabretta (TJU, Philadelphia, PA, USA), R. Arlinghaus (MDACC, Houston, TX, USA), and K. Huebner (OSU) for critical reading of the manuscript.

PY - 2010/3/5

Y1 - 2010/3/5

N2 - MicroRNAs and heterogeneous ribonucleoproteins (hnRNPs) are posttranscriptional gene regulators that bind mRNA in a sequence-specific manner. Here, we report that loss of miR-328 occurs in blast crisis chronic myelogenous leukemia (CML-BC) in a BCR/ABL dose- and kinase-dependent manner through the MAPK-hnRNP E2 pathway. Restoration of miR-328 expression rescues differentiation and impairs survival of leukemic blasts by simultaneously interacting with the translational regulator poly(rC)-binding protein hnRNP E2 and with the mRNA encoding the survival factor PIM1, respectively. The interaction with hnRNP E2 is independent of the microRNA's seed sequence and it leads to release of CEBPA mRNA from hnRNP E2-mediated translational inhibition. Altogether, these data reveal the dual ability of a microRNA to control cell fate both through base pairing with mRNA targets and through a decoy activity that interferes with the function of regulatory proteins. PaperFlick: {An electronic component is presented}.

AB - MicroRNAs and heterogeneous ribonucleoproteins (hnRNPs) are posttranscriptional gene regulators that bind mRNA in a sequence-specific manner. Here, we report that loss of miR-328 occurs in blast crisis chronic myelogenous leukemia (CML-BC) in a BCR/ABL dose- and kinase-dependent manner through the MAPK-hnRNP E2 pathway. Restoration of miR-328 expression rescues differentiation and impairs survival of leukemic blasts by simultaneously interacting with the translational regulator poly(rC)-binding protein hnRNP E2 and with the mRNA encoding the survival factor PIM1, respectively. The interaction with hnRNP E2 is independent of the microRNA's seed sequence and it leads to release of CEBPA mRNA from hnRNP E2-mediated translational inhibition. Altogether, these data reveal the dual ability of a microRNA to control cell fate both through base pairing with mRNA targets and through a decoy activity that interferes with the function of regulatory proteins. PaperFlick: {An electronic component is presented}.

KW - HUMDISEASE

KW - RNA

UR - http://www.scopus.com/inward/record.url?scp=77649133970&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649133970&partnerID=8YFLogxK

U2 - 10.1016/j.cell.2010.01.007

DO - 10.1016/j.cell.2010.01.007

M3 - Article

C2 - 20211135

AN - SCOPUS:77649133970

SN - 0092-8674

VL - 140

SP - 652

EP - 665

JO - Cell

JF - Cell

IS - 5

ER -

miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts

Abstract

Bibliographical note

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this